132 related articles for article (PubMed ID: 15244111)
21. Topiramate attenuates cerebral ischemia/reperfusion injury in gerbils via activating GABAergic signaling and inhibiting astrogliosis.
Mao X; Ji C; Sun C; Cao D; Ma P; Ji Z; Cao F; Min D; Li S; Cai J; Cao Y
Neurochem Int; 2012 Jan; 60(1):39-46. PubMed ID: 22085431
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization.
Yang Y; Shuaib A; Li Q; Siddiqui MM
Brain Res; 1998 Sep; 804(2):169-76. PubMed ID: 9757028
[TBL] [Abstract][Full Text] [Related]
23. Carbamazepine and topiramate modulation of transient and persistent sodium currents studied in HEK293 cells expressing the Na(v)1.3 alpha-subunit.
Sun GC; Werkman TR; Battefeld A; Clare JJ; Wadman WJ
Epilepsia; 2007 Apr; 48(4):774-82. PubMed ID: 17381447
[TBL] [Abstract][Full Text] [Related]
24. What's the role of topiramate in the management of patients with hyperkinetic movement disorders?
Siniscalchi A; Gallelli L; Giofrè C; De Sarro G
Pharmacol Rep; 2012; 64(1):24-30. PubMed ID: 22580517
[TBL] [Abstract][Full Text] [Related]
25. Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture.
McLean MJ; Bukhari AA; Wamil AW
Epilepsia; 2000; 41(S1):21-4. PubMed ID: 10768295
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate.
Taverna S; Sancini G; Mantegazza M; Franceschetti S; Avanzini G
J Pharmacol Exp Ther; 1999 Mar; 288(3):960-8. PubMed ID: 10027832
[TBL] [Abstract][Full Text] [Related]
27. The effect of topiramate on GABA(B) receptor, vesicular GABA transporter and paired-pulse inhibition in the gerbil hippocampus.
Kim DS; Kwak SE; Kim JE; Won MH; Choi HC; Song HK; Kim YI; Choi SY; Kang TC
Neurosci Res; 2005 Dec; 53(4):413-20. PubMed ID: 16207499
[TBL] [Abstract][Full Text] [Related]
28. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy.
Russo E; Constanti A; Ferreri G; Citraro R; De Sarro G
Neuropharmacology; 2004 May; 46(6):865-78. PubMed ID: 15033346
[TBL] [Abstract][Full Text] [Related]
29. [Current data on topiramate].
Herranz JL
Rev Neurol; 2000 Jun; 30 Suppl 1():S132-6. PubMed ID: 10904980
[TBL] [Abstract][Full Text] [Related]
30. [Topiramate, a new antiepileptic drug].
Herranz JL
Rev Neurol; 1997 Aug; 25(144):1221-5. PubMed ID: 9340155
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotection possibilities in epileptic children.
Artemowicz B; Sobaniec W
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():91-5. PubMed ID: 16119636
[TBL] [Abstract][Full Text] [Related]
32. Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent.
Frisch C; Kudin AP; Elger CE; Kunz WS; Helmstaedter C
Epilepsy Res; 2007 Feb; 73(2):173-80. PubMed ID: 17084066
[TBL] [Abstract][Full Text] [Related]
33. Protein-kinase C-dependent phosphorylation inhibits the effect of the antiepileptic drug topiramate on the persistent fraction of sodium currents.
Curia G; Aracri P; Sancini G; Mantegazza M; Avanzini G; Franceschetti S
Neuroscience; 2004; 127(1):63-8. PubMed ID: 15219669
[TBL] [Abstract][Full Text] [Related]
34. The mechanism of neuroprotection by topiramate in an animal model of epilepsy.
Kudin AP; Debska-Vielhaber G; Vielhaber S; Elger CE; Kunz WS
Epilepsia; 2004 Dec; 45(12):1478-87. PubMed ID: 15571505
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of topiramate as an anti-hyperalgesic and neuroprotective agent in the peripheral nervous system.
Bischofs S; Zelenka M; Sommer C
J Peripher Nerv Syst; 2004 Jun; 9(2):70-8. PubMed ID: 15104694
[TBL] [Abstract][Full Text] [Related]
36. Substantia nigra is an anticonvulsant site of action of topiramate in the focal pilocarpine model of limbic seizures.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Epilepsia; 2006 Sep; 47(9):1519-35. PubMed ID: 16981869
[TBL] [Abstract][Full Text] [Related]
37. Antiepileptic drugs and neuroprotection: current status and future roles.
Willmore LJ
Epilepsy Behav; 2005 Dec; 7 Suppl 3():S25-8. PubMed ID: 16239127
[TBL] [Abstract][Full Text] [Related]
38. Topiramate for smoking cessation.
Khazaal Y; Cornuz J; Bilancioni R; Zullino DF
Psychiatry Clin Neurosci; 2006 Jun; 60(3):384-8. PubMed ID: 16732758
[TBL] [Abstract][Full Text] [Related]
39. Failure of ischemic neuroprotection by potentiators of gamma-aminobutyric acid.
Madden K; Clark W; Lessov N
Clin Med Res; 2003 Apr; 1(2):119-24. PubMed ID: 15931298
[TBL] [Abstract][Full Text] [Related]
40. Topiramate rapidly raises brain GABA in epilepsy patients.
Petroff OA; Hyder F; Rothman DL; Mattson RH
Epilepsia; 2001 Apr; 42(4):543-8. PubMed ID: 11440351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
